Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients
Author:
Affiliation:
1. Department of Neurology, Medical University of Vienna, Vienna, Austria
2. Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany
Funder
not funded
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1446944
Reference137 articles.
1. Pathological mechanisms in progressive multiple sclerosis
2. The Natural History of Multiple Sclerosis: Update 1998
3. Immune-mediated CNS diseases: A review on nosological classification and clinical features
4. Defining the clinical course of multiple sclerosis: The 2013 revisions
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An update on managing patients with multiple sclerosis in primary care;JAAPA;2024-02
2. Multiple Sclerosis Diagnostic Delay and Misdiagnosis;Neurologic Clinics;2024-02
3. Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis;Pharmaceutics;2023-12-19
4. A High MCT‐Based Ketogenic Diet Suppresses Th1 and Th17 Responses to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice by Inhibiting GSDMD and JAK2‐STAT3/4 Pathways;Molecular Nutrition & Food Research;2023-12-06
5. Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis;Journal of Clinical Medicine;2023-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3